Drug Shortage Report for MYLAN-GALANTAMINE ER

Last updated on 2020-07-03 History
Report ID 119216
Drug Identification Number 02339447
Brand name MYLAN-GALANTAMINE ER
Common or Proper name GALANTAMINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) GALANTAMINE
Strength(s) 16MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 30BT, 100BT
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-07-02
Actual start date
Estimated end date 2020-07-28
Actual end date
Shortage status Actual shortage
Updated date 2020-07-03
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2020-07-03 English Compare
v2 2020-06-30 French Compare
v1 2020-06-30 English Compare